What the business is, and whether it's a good one at a fair price.
Operates a hospital-based healthcare business alongside a large pharmacy distribution network and a retail diagnostics chain. In FY26, total revenue was Rs 25,228.5 crore with net profit of Rs 2,002.7 crore. The Healthcare services segment contributed 50.1% of segment revenue (Rs 12,750.1 crore) at a 19.1% EBIT margin, while Digital health & pharmacy distribution contributed 42.5% (Rs 10,808.1 crore) at a 3.7% EBIT margin, and Retail health & diagnostics contributed 7.3% (Rs 1,865.3 crore) at a 3.9% EBIT margin. Major cost lines are other operating expenses at 21.3% of revenue, materials at 12.1% and employee costs at 11.9%, with depreciation at 3.5% and capex of Rs 1,962.0 crore (7.8% of revenue) in the year. The company has filed a composite scheme of arrangement to demerge an identified business undertaking (including Apollo Healthco and Keimed) into a new listed entity called Apollo Healthtech, with equity shareholders having approved the scheme at NCLT-convened meetings in June 2026.
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from APOLLO HOSPITALS ENTER. L's filed financials and exchange disclosures
APOLLO HOSPITALS ENTER. L is a Healthcare Services company listed on NSE and BSE, trading under the symbol APOLLOHOSP.
Yes. Over the trailing twelve months APOLLO HOSPITALS ENTER. L reported a net profit of ₹2,172 Cr on revenue of ₹26,430 Cr.
Yes. The dividend yield is 0.23% at the current price. It paid out 15% of its profit as dividend in FY26.
No. Debt stands at 0.57× equity, and it carries net debt of ₹4,847 Cr. That is lower than 13% of its 24 Hospital peers.
On trailing P/E, APOLLO HOSPITALS ENTER. L ranks 22 of 30 in Hospital — cheaper than 28% of them, against an industry median of 47.3×. This is a position, not a valuation judgement.
On a typical session APOLLO HOSPITALS ENTER. L moves 0.65% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by APOLLO HOSPITALS ENTER. L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
